Evidence map›Paper›PMID 29247242›Full record

ArticleScientific reports2017

Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.

C Lutz, B Weder, A Hünerwadel, S Fagagnini, B Lang, N Beerenwinkel, J B Rossel, G Rogler, B Misselwitz, M Hausmann

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

C LutzDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
B WederDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
A HünerwadelDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
S FagagniniDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
B LangDepartment of Biosystems Sciences and Engineering, ETH Zurich, Basel, Switzerland.
N BeerenwinkelDepartment of Biosystems Sciences and Engineering, ETH Zurich, Basel, Switzerland.ORCID 0000-0002-0573-6119
J B RosselInstitute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
G RoglerDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
B MisselwitzDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland.
M HausmannDepartment of Gastroenterology and Hepatology, University Hospital, Zurich, Switzerland. martin.hausmann@usz.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of the immune response to microbiota is associated with inflammatory bowel disease (IBD), which can trigger intestinal fibrosis. MyD88 is a key component of microbiota signalling but its influence on intestinal fibrosis has not been clarified. Small bowel resections from donor-mice were transplanted subcutaneously into the neck of recipients C57BL/6 B6-MyD88tm1 Aki (MyD88

Indexed as

AnimalsCollagenDisease Models, AnimalFibrosisInflammationIntestinal MucosaIntestinesMatrix Metalloproteinase 9MiceMice, Inbred C57BLMyeloid Differentiation Factor 88NeutrophilsSignal TransductionTransforming Growth Factor beta1CollagenMatrix Metalloproteinase 9Myd88 protein, mouseMyeloid Differentiation Factor 88Transforming Growth Factor beta1

Identifiers

PMID29247242
PMCPMC5732165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.